PROVIDER PROFILE · NPI 1699740324

Carlos Manrique De LaraM.D., F.A.C.S.

PRACTICECARLOS MANRIQUE DE LARA MDPASee all providers at this practice →

OphthalmologyEdinburg, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

629

Unique beneficiaries

—

Total services

748

Distinct HCPCS

Medicare payment

$88K

Peer benchmark

Total Medicare services vs. 1,238 Ophthalmology providers in TX — bottom quintile (cohort median 1,864).

PRESCRIBING · PART D · 2024

Total Rx claims

163

Beneficiaries

—

Total drug cost

$29K

Distinct drugs

Brand share

48.5%

Top prescribed drugs

Latanoprost45 claims

Moxifloxacin Hcl40 claims

Loteprednol Etabonate25 claims

Prednisolone Acetate17 claims

Cyclosporine14 claims

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

0.0

Cost

51.7

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$309

Payment records

By payment type

Food and Beverage$309

REFERRAL NETWORK

Where Carlos Manrique De Lara's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Michelle Cisneros Optometry · Odessa, TX	167	276
DOCTORS HOSPITAL AT RENAISSANCE, LTD	146	537
Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX	34	96
FLOREZ, MARCO	11	21

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history